ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
The paper provides the clinical characteristics of etoricoxib (Arcoxia), a new selective cyclooxygenase-2 inhibitor having unique properties, which permits it to be distinguished among other nonsteroidal anti-inflammatory agents.
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Russo |
| Хэвлэсэн: |
IMA-PRESS LLC
2009-06-01
|
| Цуврал: | Современная ревматология |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://mrj.ima-press.net/mrj/article/view/229 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|